Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (6): 89-95.doi: 10.6040/j.issn.1673-3770.0.2022.350

• 论著 • Previous Articles     Next Articles

Effects of Helicobacter pylori infection on salivary pepsin concentration in patients with symptomatic laryngopharyngeal reflux

SHAO Na, ZHANG Qingqing, LIU Xiaohong, XIE Meng, GUO Ruixin, MA Sijing, LIU Haiqin, REN Xiaoyong, LUO Huanan   

  1. Department of Otolaryngology Head and Neck Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, Shaanxi, China
  • Published:2022-12-07

Abstract: Objective To examine the effect of Helicobacter pylori(HP)infection on the salivary pepsin concentration in patients with symptomatic laryngopharyngeal reflux(LPR). Methods We enrolled 229 newly diagnosed outpatients with LPR who complained of non-specific symptoms, including pharyngeal foreign body sensation and repeated throat clearing. HP infection was confirmed by performing a 14C breath test, and patients in the HP-positive and HP-negative groups were prescribed HP eradication treatment(triple therapy)and proton pump inhibitors, respectively. Saliva samples were collected from all patients at initial diagnosis and post-treatment follow-ups(the HP-positive group underwent the 14C breath test at follow-up visits), and differences in the reflux symptom index(RSI)score, the reflux finding score(RFS)score, and salivary pepsin concentration were compared before and after treatment. Results There were no significant differences in total RSI and RFS scores between HP-positive and HP-negative patients with LPR(11.00 vs 9.00, P=0.077; 8.50 vs 9.00, P=0.415). However, scores for symptoms and signs such as hoarseness(P=0.005), annoying cough(P=0.016), vocal cord edema(P=0.002), and salivary pepsin concentration(94.90 μg/mL vs 45.28 μg/mL, P<0.001)were significantly higher in HP-positive patients than those in HP-negative patients with LPR. Furthermore, compared with HP-negative patients with LPR, HP-positive patients exhibited a more significant reduction in RSI and RFS scores and salivary pepsin concentrations after treatment(P=0.012,P=0.019,P=0.013,P=0.027). Conclusion HP eradication therapy could significantly reduce scores of specific symptoms and signs, as well as the salivary pepsin concentration in HP-infected patients with LPR, suggesting that HP infection plays an important role in the pathogenesis of LPR.

Key words: Helicobacter pylori infection, Laryngopharyngeal reflux, Saliva pepsin, Reflux symptom index, Reflux finding score

CLC Number: 

  • R766.5
[1] Krause AJ, Walsh EH, Weissbrod PA, et al. An update on current treatment strategies for laryngopharyngeal reflux symptoms[J]. Ann N Y Acad Sci, 2022, 1510(1): 5-17. doi:10.1111/nyas.14728.
[2] O'Hara J, Fisher H, Hayes L, et al. ‘Persistent throat symptoms’ versus ‘laryngopharyngeal reflux’: a cross-sectional study refining the clinical condition[J]. BMJ Open Gastroenterol, 2022, 9(1): e000850. doi:10.1136/bmjgast-2021-000850.
[3] Kowalik K, Krzeski A. The role of pepsin in the laryngopharyngeal reflux[J]. Pol Otolaryngol, 2017, 71(6): 7-13. doi:10.5604/01.3001.0010.7194.
[4] Runggaldier D, Hente J, Brockmann-Bauser M, et al. Current possibilities and challenges in the diagnosis of laryngopharyngeal reflux[J]. HNO, 2021, 69(11): 861-867. doi:10.1007/s00106-021-01006-3.
[5] Goel AN, Omorogbe A, Hackett A, et al. Risk factors for multiple tympanostomy tube placements in children: systematic review and meta-analysis[J]. Laryngoscope, 2021, 131(7): E2363-E2370. doi:10.1002/lary.29342.
[6] 曾宪廷, 王广科, 孙占伟, 等. 伴咽喉反流的难治性鼻窦炎术后应用质子泵抑制剂的疗效观察[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512. ZENG Xianting, WANG Guangke, SUN Zhanwei, et al. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512.
[7] Lechien JR, Saussez S, Muls V, et al. Laryngopharyngeal reflux: evolution and predictive value of symptoms and pH-impedance features on clinical evolution[J]. Otolaryngol Head Neck Surg, 2022: 1945998221075009. doi:10.1177/01945998221075009.
[8] 孙喆喆, 吴玮, 王刚. 管腔内pH监测在反流性疾病中的应用[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 90-94. doi:10.6040/j.issn.1673-3770.0.2019.036. SUN Zhezhe, WU Wwei, WANG Gang. Utility of intraluminal pH monitoring in reflux diseases[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 90-94. doi:10.6040/j.issn.1673-3770.0.2019.036.
[9] Li YD, Xu GF, Zhou BD, et al. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets[J]. Eur Arch Otorhinolaryngol, 2022, 279(6): 2743-2752. doi:10.1007/s00405-021-07201-w.
[10] Wang JS, Li JR, Nie Q, et al. Are multiple tests necessary for salivary pepsin detection in the diagnosis of laryngopharyngeal reflux? [J]. Otolaryngol Head Neck Surg, 2022, 166(3): 477-481. doi:10.1177/01945998211026837.
[11] Yang H, Hu B. Immunological perspective: Helicobacter pylori infection and gastritis[J]. Mediators Inflamm, 2022: 2944156. doi:10.1155/2022/2944156.[PubMed]
[12] Malik TF, Gnanapandithan K, Singh K. Peptic Ulcer Disease[M]. In: StatPearls [Internet]. Treasure Island(FL): StatPearls Publishing, 2022: 11.
[13] Oster P, Vaillant L, Riva E, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J]. Gut, 2022, 71(3): 457-466. doi:10.1136/gutjnl-2020-323392.
[14] Gao PP, Cai N, Yang XR, et al. Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China[J]. Int J Cancer, 2022, 150(2): 243-252. doi:10.1002/ijc.33801.
[15] Yan P, Yu BC, Li M, et al. Association between nonalcoholic fatty liver disease and Helicobacter pylori infection in Dali City, China[J]. Saudi Med J, 2021, 42(7): 735-741. doi:10.15537/smj.2021.42.7.20210040.
[16] Tezer MS, Kockar MC, Koçkar O, et al. Laryngopharyngeal reflux finding scores correlate with gastroesophageal reflux disease and Helicobacter pylori expression[J]. Acta Otolaryngol, 2006, 126(9): 958-961. doi:10.1080/00016480500529314.
[17] Oridate N, Takeda H, Yamamoto J, et al. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms[J]. Laryngoscope, 2006, 116(4): 547-553. doi:10.1097/01.mLG.0000201907.24514.6A.
[18] Toros SZ, Toros AB, Yüksel OD, et al. Association of laryngopharyngeal manifestations and gastroesophageal reflux[J]. Eur Arch Otorhinolaryngol, 2009, 266(3): 403-409. doi:10.1007/s00405-008-0761-2.
[19] 侯波, 梁程程, 魏东敏, 等. 耳鼻咽喉门诊咽喉良性病变老年患者喉镜观察与嗓音声学分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 20-25. doi:10.6040/j.issn.1673-3770.1.2020.111. HOU Bo, LIANG Chengcheng, WEI Dongmin, et al. Laryngoscopy observation and voice acoustic analysis of elderly patients with benign laryngopharyngeal lesions in an ENT out-patient clinic[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(2): 20-25. doi:10.6040/j.issn.1673-3770.1.2020.111.
[20] Lechien JR, Schindler A, Hamdan AL, et al. The development of new clinical instruments in laryngopharyngeal reflux disease: the international project of young otolaryngologists of the International Federation of Oto-rhino-laryngological Societies[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2018, 135(5S): S85-S91. doi:10.1016/j.anorl.2018.05.013.
[21] 蔡建平. 奥美拉唑、克拉霉素、阿莫西林三联疗法对幽门螺杆菌感染的治疗效果[J]. 泰山医学院学报, 2014, 35(5): 441-442. doi:10.3969/j.issn.1004-7115.2014.05.046.
[22] 张青青, 谢萌, 郭瑞昕, 等. 质子泵抑制剂对咽喉反流患者唾液胃蛋白酶浓度的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(11): 965-970. doi:10.13201/j.issn.2096-7993.2021.11.002. ZHANG Qingqing, XIE Meng, GUO Ruixin, et al. Effect of proton pump inhibitort on salivary pepsin concentration in patients with laryngopharyngeal reflux[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2021, 35(11): 965-970. doi:10.13201/j.issn.2096-7993.2021.11.002.
[23] Singh GB, Yvette War G, Shukla S, et al. The role of Helicobacter Pylori and laryngopharyngeal reflux in recurrent tonsillitis[J]. Int J Pediatr Otorhinolaryngol, 2020, 138(2): 110376. doi:10.1016/j.ijporl.2020.110376.
[24] Yılmaz T, Bajin MD, Günaydın RÖ, et al. Laryngopharyngeal reflux and Helicobacter pylori[J]. World J Gastroenterol, 2014, 20(27): 8964-8970. doi:10.3748/wjg.v20.i27.8964.
[25] du PY, Zong SM, Wen YY, et al. Association between Helicobacter pylori and otitis media with effusion in children: a systematic review[J]. Int J Pediatr Otorhinolaryngol, 2020, 135: 110091. doi:10.1016/j.ijporl.2020.110091.
[26] Flores-Treviño CE, Urrutia-Baca VH, Gómez-Flores R, et al. Molecular detection of Helicobacter pylori based on the presence of cagA and vacA virulence genes in dental plaque from patients with periodontitis[J]. J Dent Sci, 2019, 14(2): 163-170. doi:10.1016/j.jds.2019.01.010.
[27] Chang SH, Hsieh PL, Tsai GJ. Chitosan inhibits Helicobacter pylori growth and urease production and prevents its infection of human gastric carcinoma cells[J]. Mar Drugs, 2020, 18(11): 542. doi:10.3390/md18110542.
[28] Gu HY. Role of flagella in the pathogenesis of Helicobacter pylori[J]. Curr Microbiol, 2017, 74(7): 863-869. doi:10.1007/s00284-017-1256-4.
[29] Jeyamani L, Jayarajan J, Leelakrishnan V, et al. CagA and VacA genes of Helicobacter pylori and their clinical relevance[J]. Indian J Pathol Microbiol, 2018, 61(1): 66-69. doi:10.4103/IJPM.IJPM_234_17.
[30] Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis[J]. Aliment Pharmacol Ther, 2004, 20(1): 165-170. doi:10.1111/j.1365-2036.2004.01974.x.
[31] Lv YP, Teng YS, Mao FY, et al. Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis[J]. Cell Death Dis, 2018, 9(5): 457. doi:10.1038/s41419-018-0493-1.
[32] Shishkina VV, Klochkova SV, Alexeeva NT, et al. Discussion of the immunomorphological role of interactions between mast cells and Helicobacter pylori in the gastric mucosa[J]. Vopr Pitan, 2022, 91(1): 98-108. doi:10.33029/0042-8833-2022-91-1-98-108.
[33] Baj J, Korona-Gowniak I, Forma A, et al. Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in Helicobacter pylori-induced gastric cancer[J]. Cells, 2020, 9(4): 1055. doi:10.3390/cells9041055.
[34] Siupsinskiene N, Katutiene I, Jonikiene V, et al. Helicobacter pylori in the tonsillar tissue: a possible association with chronic tonsillitis and laryngopharyngeal reflux[J]. J Laryngol Otol, 2017, 131(6): 549-556. doi:10.1017/S0022215117000597.
[35] Baj J, Forma A, Sitarz M, et al. Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment[J]. Cells, 2020, 10(1): E27. doi:10.3390/cells10010027.
[36] Yao XB, Smolka AJ. Gastric parietal cell physiology and Helicobacter pylori-induced disease[J]. Gastroenterology, 2019, 156(8): 2158-2173. doi:10.1053/j.gastro.2019.02.036.
[37] Scida S, Russo M, Miraglia C, et al. Relationship between Helicobacter pylori infection and GERD[J]. Acta Biomed, 2018, 89(8-S): 40-43. doi:10.23750/abm.v89i8-S.7918.
[38] Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease[J]. Esophagus, 2019, 16(1): 52-62. doi:10.1007/s10388-018-0637-5.
[39] Chung SJ, Lim SH, Choi J, et al. Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic area: a matched case-control study of 5, 616 health check-up koreans[J]. J Neurogastroenterol Motil, 2011, 17(3): 267-273. doi:10.5056/jnm.2011.17.3.267.
[40] Liu L, Gao HW, Wang HJ, et al. Comparison of esophageal function tests to investigate the effect of Helicobacter pylori infection on gastroesophageal reflux disease(GERD)[J]. Med Sci Monit, 2018, 24: 4791-4797. doi:10.12659/MSM.908051.
[41] Ashktorab H, Entezari O, Nouraie M, et al. Helicobacter pylori protection against reflux esophagitis[J]. Dig Dis Sci, 2012, 57(11): 2924-2928. doi:10.1007/s10620-012-2349-3.
[42] Heda R, Toro F, Tombazzi CR. Physiology, pepsin[J].In: StatPearls [Internet]. Treasure Island(FL): StatPearls Publishing; 2022:8.
[43] Hoppo T, Zaidi AH, Matsui D, et al. Sep70/Pepsin expression in hypopharynx combined with hypopharyngeal multichannel intraluminal impedance increases diagnostic sensitivity of laryngopharyngeal reflux[J]. Surg Endosc, 2018, 32(5): 2434-2441. doi:10.1007/s00464-017-5943-9.
[44] Liu DL, Qian TT, Sun S, et al. Laryngopharyngeal reflux and inflammatory responses in mucosal barrier dysfunction of the upper aerodigestive tract[J]. J Inflamm Res, 2020, 13: 1291-1304. doi:10.2147/JIR.S282809.
[45] Do gru M, Kuran G, Haytoglu S, et al. Role of laryngopharyngeal reflux in the pathogenesis of otitis media with effusion[J]. J Int Adv Otol, 2015, 11(1): 66-71. doi:10.5152/iao.2015.642.
[46] di Mario F, Crafa P, Barchi A, et al. Pepsinogen II in gastritis and Helicobacter pylori infection[J]. Helicobacter, 2022, 27(2): e12872. doi:10.1111/hel.12872.
[47] Yuan L, Zhao JB, Zhou YL, et al. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area[J]. World J Gastroenterol, 2020, 26(25): 3673-3685. doi:10.3748/wjg.v26.i25.3673.
[48] Bulmer DM, Ali MS, Brownlee IA, et al. Laryngeal mucosa: its susceptibility to damage by acid and pepsin[J]. Laryngoscope, 2010, 120(4): 777-782. doi:10.1002/lary.20665.
[49] Kumral TL, Gökden Y, Saltürk Z, et al. The effect of gastric Helicobacter pylori colonization on nasal functions[J]. Ear Nose Throat J, 2019, 98(6): 346-350. doi:10.1177/0145561319840825.
[1] WU Wei, WANG Lei, CHEN Sheng, LI Lianyong, WANG Gang. Multidisciplinary research and advances in gastro-oesophageal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 1-14.
[2] LIU Lianlian, LI Jinrang. Obstructive sleep apnea and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 15-22.
[3] ZHANG Li, ZHANG Mengru, Alimire Aierken, QIU Zhongmin. Role of pharyngeal reflux in common respiratory diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 23-29.
[4] HU Zhiwei, CHEN Dong, YANG Dong, WU Jimin. Diagnosis and treatment of gastroesophageal airway reflux disease: based on related consensus and guidelines from 2020 to 2024 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 30-38.
[5] ZHAO Jianing, CUI Yuanxin, WANG Dan, ZHAO Ming. Exploration of the relationship between laryngopharyngeal reflux and recurrent respiratory papilloma and its mechanism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 39-45.
[6] ZHANG Shan, CHEN Qiu, ZHOU Fangwei, MA Yifei. Research progress of biomarkers in laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 46-54.
[7] ZHOU Shitong, YANG Yanyan, YANG Yucheng, FANG Hongyan. Pepsin and laryngopharyngeal reflux disease: from pathogenic mechanisms to potential risk factors for pharyngeal and laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 55-60.
[8] XI Xiaoyu, SUI Xinke, CHEN Sheng, LI Lianyong, ZHONG Changqing. Endoscopic treatment of laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 61-65.
[9] NIU Yanyan, GU Wei, JIN Xiaofeng, HUO Hong, YANG Dahai, CUI Tingting, WANG Jian. Expression analysis of pepsin in vocal cord leukoplakia tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 66-70.
[10] WANG Lei, WANG Gang, SUN Zhezhe, LIU Hongdan, HAN Haolun, LI Baowei, ZHANG Xiaoli, WU Wei. Correlations between vocal cord hyperplastic lesions, vocal cord leukoplakia, chronic laryngopharyngitis, and laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 71-77.
[11] CUI Xiaohuan, YIN Longlong, ZHANG Yanping, JIANG Xingwang, LI Lina. Study of the association between salivary microbiota and reflux symptoms in patients with laryngopharyngeal reflux [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 78-84.
[12] SUN Zhezhe, WANG Gang, WANG Lei, LI Baowei, HAN Haolun, LIU Hongdan, ZHANG Xiaoli, WU Wei. Influence of body positions on laryngopharyngeal reflux disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 91-95.
[13] WEI Xin, XING Dongsheng, ZHAI Zhenwei, YAN Aihui, LIU Zhenyu, CAO Hongwei. Study of the laryngeal reflux symptom index and analysis of influencing factors in pregnant women [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 96-102.
[14] LI Fengjiang, WEI Jie, LIU Hongdan, ZHANG Li, ZHAO Weichao, WU Nana, WANG Lei, WU Wei, WANG Ruijuan. Gastroesophageal reflux disease and laryngopharyngeal reflux disease in 25 elderly patients with pneumonia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 103-107.
[15] LIU Xiaohong, ZHANG Qingqing, GUO Ruixin, QIANG Yin, SHI Yao, YANG Haonan, CAO Nan, JIA Wei, XIE Meng. Analysis of reflux types in patients with laryngeal reflux associated with Helicobacter pylori infection [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(6): 108-114.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!